Gilead Sciences, Inc. (GILD)

Gilead Sciences, Inc. achieves an AlphaScore of 74/100 in the Healthcare sector. Key fundamental metrics include a high return on equity of 37.48% and a solid gross margin of 78.83%. A key strength is the robust quality subscore of 86, reflecting strong operational performance. A primary risk is the elevated debt-to-equity ratio of 1.1, indicating a heavier reliance on debt financing under current conditions.

Written 11/10/2026, 00:23:19 UTC · Snapshot 11/10/2026